Sentosa SQ OncoKey Core Automated Workflow (CE-IVD)
The Sentosa SQ OncoKey Core Panel is a family of panels consisting of three panels: Sentosa SQ NSCLC Panel, Sentosa SQ CRC Panel and Sentosa SQ Thyroid Cancer Panel. All panels are next-generation sequencing (NGS)-based in vitro diagnostic tests. These CE-IVD marked tests are automated on the Sentosa workflow.
The Sentosa SQ OncoKey Core Panel is intended to be used on the Sentosa SX101 instrument, in conjunction with the Sentosa SX FFPE II gDNA Kit, Sentosa ST401 and Sentosa SQ301 instruments. On this automated workflow, up to 7 samples can be automatically processed and analysed within 2.5 days.
The Sentosa SQ OncoKey Core Panel is intended to be used as a test to aid the oncologist in clinical decision-making. Results should be used in conjunction with other available laboratory and clinical information and are not intended for use as a stand-alone diagnostic test or disease monitoring.
Sentosa SQ OncoKey Core Manual Workflow (RUO)
The Sentosa SQ OncoKey Core Primer Set (96) provides the users a manual solution to test for NSCLC, CRC and thyroid cancer. This test contains the Core Primer pool, OncoKey System Control and barcoded DNA adapters sufficient for up to 16 libraries per run (96 reactions in total). The Sentosa SQ OncoKey Core Primer Set is for research use only (RUO), and not for use in diagnostic procedures.
The Sentosa SQ OncoKey Core Primer Set is designed to be used with the Ion AmpliSeq DNA Library Preparation kits for multiplex targeted libraries from DNA for sequencing on the Sentosa SQ301 instrument or Ion PGM/S5/S5 XL systems, following the manufacturer's instructions for the details of the procedure.
|
Target Genes |
NSCLC | |
|
Number of Target Mutations |
Amplicon Locations in Exon(s) |
|
| NRAS | 19 | 2, 3, 4 |
| CTNNB1 | 5 | 3 |
| PIK3CA | 14 | 11, 22 |
| FGFR3 | 9 | 7, 9, 14 |
| KIT | 8 | 11, 13, 17 |
| EGFR | 10 | 18, 19, 20, 21 |
| BRAF | 15 | 11, 15 |
| RET | 1 | 16 |
| PTEN | 3 | 5, 7 |
| KRAS | 22 | 2, 3, 4 |
| TP53 | 7 | 4, 6, 7 |
| Total | 113 | |
|
Target Genes |
CRC | |
|
Number of Target Mutations |
Amplicon Locations in Exon(s) |
|
| NRAS | 19 | 2, 3, 4 |
| CTNNB1 | 5 | 3 |
| PIK3CA | 14 | 11, 22 |
| FGFR3 | 9 | 7, 9, 14 |
| KIT | 8 | 11, 13, 17 |
| EGFR | 9 | 18, 19, 20, 21 |
| BRAF | 15 | 11, 15 |
| RET | 1 | 16 |
| PTEN | 3 | 5, 7 |
| KRAS | 22 | 2, 3, 4 |
| TP53 | 7 | 4, 6, 7 |
| Total | 112 | |
|
Target Genes |
Thyroid | |
|
Number of Target Mutations |
Amplicon Locations in Exon(s) |
|
| NRAS | 19 | 2, 3, 4 |
| CTNNB1 | 5 | 3 |
| PIK3CA | 14 | 11, 22 |
| FGFR3 | 9 | 7, 9, 14 |
| cKIT | - | - |
| EGFR | 10 | 18, 19, 20, 21 |
| BRAF | 15 | 11, 15 |
| RET | 1 | 16 |
| PTEN | 3 | 5, 7 |
| KRAS | 22 | 2, 3, 4 |
| TP53 | 7 | 4, 6, 7 |
| Total | 105 | |
Supporting Clinical Decision-Making:
Providing Laboratory Efficiency:
*Not available with/applicable for the Oncokey Core Primer Set (RUO)
| Attribute | NSCLC | CRC | Thyroid |
| Regulatory Status | CE-IVD, TGA, HSA | ||
| No. of Genes | 11 | 11 | 10 |
| No. of Amplicons | 28 | 28 | 25 |
| Target Mutations | 113 | 112 | 105 |
| Sample Input | 10 µm section of FFPE sample with > 10% tumor content | ||
| Sample Throughput | 7 clinical samples and 1 system control sample | ||
| Median Coverage | ≥ 1.000X | ||
| Mutation Detection Sensitivity | 5% - 10% | ||
| Hands on Time | ≤ 3 hours | ||
| Turn around Time | 2.5 days including overnight sample incubation | ||
| Pack Size | 4x8 | ||
| Sentosa Oncology Panels Flyer | CE-IVD | EN |
| Product | Pack Size | Item Number |
|---|---|---|
| Sentosa SQ CRC Panel Reagents (4x8) CE-IVD | 4x8 | 300261 |
| Sentosa SQ CRC Panel Reagents (4x8) RUO | 4x8 | 300262 |
| Sentosa SQ NSCLC Panel Reagents (4x8) CE-IVD | 4x8 | 300356 |
| Sentosa SQ NSCLC Panel Reagents (4x8) RUO | 4x8 | 300357 |
| Sentosa SQ OncoKey Core Primer Set (96) RUO | 96 | 300694 |
| Sentosa SQ Oncology Solutions (4x8) CE-IVD | 4x8 | 300336 |
| Sentosa SQ Oncology Solutions (4x8) RUO | 4x8 | 300224 |
| Sentosa SQ Thyroid Cancer Reagents (4x8) RUO | 4x8 | 300382 |
| Sentosa SQ Thyroid Cancer Reagents (CE-IVD) | 4x8 | 300381 |
| VELA Analytics Software | 480175 |
For availability in your country, please contact your Vela Diagnostics sales representative. Availability is subject to country's regulatory approval.
For more product related documents, please contact us.